Shares of Portage Biotech Inc. more than doubled in after-hours trading on Thursday as the company reported promising ...

Hedy Lee Kindler, MD, shares new mesothelioma guidelines that have been released by the American Society of Clinical Oncology ...

About Portage Biotech Portage Biotech is a clinical-stage immuno-oncology company advancing a pipeline of novel biologics to transform the immune system’s ability to fight cancer. For more information ...

Investing.com -- Shares of Portage Biotech Inc. ( NASDAQ: PRTG) surged 29% following the presentation of new preclinical data for its mesothelioma treatment, PORT-7. The company unveiled these ...

Portage Biotech have more than doubled in the after-hours market after the company reported preclinical results for PORT-7 in a murine mesothelioma model. In the Thursday late trading session, the ...

The development of surgical treatments for mesothelioma has followed a path similar to that of other solid tumors. The functional approach to treating solid tumors is a two-step process ...

While cancer research has experienced significant developments in the past two decades, resulting in considerable improvements in survival rates, for some cancers, progress is painfully slow.  Most of ...

After being used since the 1940s in various industries, asbestos is now linked to severe health risks, including asbestosis, ...

Portage Biotech (PRTG) presented new preclinical data for PORT-7, a selective Adenosine A2B receptor inhibitor. The new data demonstrate both ...

Biliary Tract Cancer (BTC): KEYTRUDA may be combined with chemotherapy medicines to treat BTC, a cancer that affects the bile ducts or gallbladder. This treatment is for adults when the cancer has ...

Mesothelioma symptoms like a cough and shortness of breath can resemble bronchitis, but these diseases have different causes ...